Aptamol Technologies is an early‑stage deep‑tech biosciences initiative dedicated to developing aptamer-enabled molecular platforms for research, healthcare, and emerging diagnostic applications. We build robust, tunable, and highly specific sensing systems designed to enable next‑generation detection technologies across biomedical and environmental domains.
As scientific validation and prototype development are underway, AptaMol operates in a structured, limited‑disclosure mode. This page serves as an interim presence while we complete foundational R&D and advance our intellectual property portfolio.
We aim to build scalable molecular technologies that combine the precision, stability, and tunability of aptamers - enabling transformative advancements in biosensing, molecular diagnostics and RNA-centric detection platforms.
Email: contact@aptamol.com
Location: India